cohorts and the commencement of the Multiple Ascending Dose (MAD) cohorts in its ongoing Phase 1a/b study of PALI-2108 for the treatment of Ulcerative Colitis (UC). Preliminary data from the SAD ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback